NasdaqGS - Nasdaq Real Time Price • USD
TherapeuticsMD, Inc. (TXMD)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:33 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -3.13 | 8.23 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 500k | 502k | 1.3M | 9M |
Low Estimate | 500k | 600k | 2M | 9M |
High Estimate | 500k | 600k | 2M | 9M |
Year Ago Sales | 20.92M | 1.15M | 69.96M | 1.3M |
Sales Growth (year/est) | -97.60% | -56.40% | -98.10% | 591.20% |
Earnings History
CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 3/31/2023 | 6/30/2023 |
---|---|---|---|---|
EPS Est. | -0.57 | -1.11 | 0.06 | -0.07 |
EPS Actual | -3.13 | 8.23 | -0.37 | -0.24 |
Difference | -2.56 | 9.34 | -0.43 | -0.17 |
Surprise % | -449.10% | 841.40% | -716.70% | -242.90% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
30 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
60 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
90 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | TXMD | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 6.50% |
Next Qtr. | -- | -- | -- | 12.00% |
Current Year | -- | -- | -- | 5.30% |
Next Year | -- | -- | -- | 13.10% |
Next 5 Years (per annum) | 17.60% | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | Cantor Fitzgerald: Neutral to Neutral | 8/17/2023 |
Reiterates | Cantor Fitzgerald: Neutral | 7/13/2022 |
Downgrade | HC Wainwright & Co.: Buy to Neutral | 6/7/2022 |
Related Tickers
RMTI Rockwell Medical, Inc.
1.4550
-3.64%
MITRA.BR Mithra Pharmaceuticals SA
0.2160
-1.82%
GHSI Guardion Health Sciences, Inc.
7.90
-2.83%
GRNF GRN Holding Corporation
0.0710
0.00%
WRHLF Love Hemp Group Plc
0.0000
0.00%
0950.HK Lee's Pharmaceutical Holdings Limited
1.080
-0.92%
CPIX Cumberland Pharmaceuticals Inc.
1.7600
+7.65%
AGRX Agile Therapeutics, Inc.
0.4000
0.00%
CATV 4Cable TV International, Inc.
0.0010
+11.11%
TKNO Alpha Teknova, Inc.
1.7300
+0.58%